Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 17, 2009
Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipientsM D Pescovitz, R B Ettenger, C F Strife, et al.
Immunological Investigations|April 1, 1993
IDDM patients' sera recognize a novel 30-kD pancreatic autoantigen related to chymotrypsinogenY J Kim, Z Zhou, J Hurtado, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 19, 2008
Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokineticsE van Gurp, W Weimar, R Gaston, et al.
Transplantation Proceedings|November 23, 2006
In vitro monitoring of in vivo development of human anti-thymoglobulin antibodies by ELISAB K Book, M D Pescovitz, A Agarwal, et al.
Transplantation|May 1, 1988
Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrowK Sakamoto, D H Sachs, S Shimada, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2007
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipientsT G Heffron, M D Pescovitz, S Florman, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipientsM D Pescovitz, J Rabkin, R M Merion, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2007
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimusF Vincenti, S Friman, E Scheuermann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 19, 2016
Effect of Treatment With Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting TransplantationM A Mujtaba, W J Komocsar, E Nantz, et al.
Veterinary Immunology and Immunopathology|May 20, 1998
Analyses of monoclonal antibodies reacting with porcine CD5: results from the Second International Swine CD WorkshopM D Pescovitz, B K Book, B Aasted, et al.
Pageof 11